Translational Development Acquisition CORP Schedule 13G passive stakes

Meteora Capital, LLC, through its managed funds, has disclosed beneficial ownership of 919,000 shares, representing 6.27% of the Class A Common Stock of Translational Development Acquisition Corp.

Linden Capital L.P. and associated entities have filed an amendment to their Schedule 13G, reporting beneficial ownership of Translational Development Acquisition Corp. Class A Ordinary Shares.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have reported a beneficial ownership of 1,056,879 Class A ordinary shares, representing 7.2% of the outstanding shares in Translational Development Acquisition Corp.

Wolverine Asset Management, LLC and affiliated entities report beneficial ownership of 4.89% of Translational Development Acquisition Corp.'s Class A Ordinary Shares as of June 30, 2026.

Linden Capital L.P. and affiliated entities report beneficial ownership of 950,000 Class A Ordinary Shares, representing approximately 5.5% of the outstanding shares of Translational Development Acquisition Corp.

Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed a Schedule 13G, reporting beneficial ownership of 6.1% of Translational Development Acquisition Corp.'s Class A ordinary shares as of March 31, 2026.

Wolverine Asset Management and affiliated entities reported a 9.03% beneficial ownership stake in Translational Development Acquisition Corp.'s Class A ordinary shares.

Bank of Montreal and its affiliates have reported a beneficial ownership of 4.64% in Translational Development Acquisition Corp.'s Class A Ordinary Shares.

Wolverine Asset Management LLC and affiliated entities have disclosed a beneficial ownership of 7.85% in Translational Development Acquisition Corp.'s Class A ordinary shares as of June 30, 2025.

Healthcare of Ontario Pension Plan Trust Fund (HOOPP) has filed an amended Schedule 13G, reporting beneficial ownership of 400,000 Class A ordinary shares, representing 2.3% of Translational Development Acquisition Corp.

AQR Capital Management, LLC and its affiliates have filed an amended Schedule 13G, disclosing a beneficial ownership of 6.38% in Translational Development Acquisition Corp.'s Class A ordinary shares as of March 31, 2025.

Bank of Montreal and its affiliates have disclosed a beneficial ownership of 5.79% in Translational Development Acquisition Corp.'s Class A Ordinary Shares, totaling 1,000,000 shares, as of March 31, 2025.

Wolverine Asset Management LLC and affiliated entities have reported a collective beneficial ownership of 6.24% in Translational Development Acquisition Corp.'s Class A ordinary shares.

The Healthcare of Ontario Pension Plan Trust Fund (HOOPP) has disclosed a beneficial ownership of 5.2% in Translational Development Acquisition Corp., a blank check company, as of December 31, 2024.

AQR Capital Management and its affiliates have disclosed a passive 8.61% beneficial ownership stake in Translational Development Acquisition Corp. as of December 31, 2024.

Magnetar Financial LLC and its affiliated entities have disclosed a beneficial ownership of 7.53% in Translational Development Acquisition Corp., totaling 1.3 million Class A ordinary shares.